ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500257 announcements Lupin Ltd. announcements and dividends declared BSE

Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257

Lupin Ltd. 500257 listed on BSE and deals in

Announcements and dividends declared by Lupin Ltd. 500257

Drug maker Lupin inks licensing pact with Galenicum for injectable Semaglutide
Drug maker Lupin announced a significant partnership. Its subsidiary, Lupin Atlantis Holdings SA, has signed an agreement with Galenicum Health. This collaboration focuses on diabetes and weight management medication, specifically injectable Semaglutide. G
Announcement as on 21 January 2026

Lupin inks licensing pact with Neopharmed for Plasil brand in Philippines, Brazil
Pharma major Lupin Limited has secured exclusive marketing rights for the gastroenterology brand Plasil in the Philippines and Brazil. Subsidiaries in these nations inked a deal with Italy's Neopharmed Gentili S.p.A. This move will boost Lupin's gastroente
Announcement as on 18 December 2025

Lupin gets USFDA nod for multiple sclerosis drug
Drug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tentative approval from the USFDA for Siponimod Tablets. This new product will be manufactured at Lupin's Pithampur facili
Announcement as on 05 December 2025

Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned Vitabiotics
Indian drugmaker Lupin and private equity firms are exploring the acquisition of UK's Vitabiotics. The deal is valued at approximately one billion pounds. Several Indian companies had previously considered the acquisition but stepped back due to valuation
Announcement as on 01 December 2025

Lupin gets USFDA nod for biosimilar drug
Lupin gets USFDA approval for Armlupeg, a biosimilar to Neulasta, to treat neutropenia in cancer patients. The drug will be manufactured at Lupin’s Pune facility. Armlupeg aims to reduce infection risk from chemotherapy, and Lupin plans to expand its US bi
Announcement as on 01 December 2025

Announcements by Lupin Ltd. first page | Next page |

500257 Lupin Ltd. current price & indicator signals

Moving Averages for Lupin Ltd.

  • 5Day Average: 2157.18
  • 12Day Average: 2175.77
  • 20Day Average: 2146.7
  • 50Day Average: 2103.83
  • 100Day Average: 2034.05
  • 150Day Average: 2001.68
  • 200Day Average: 2003.94

500257 Indicators & signals

Indicator MACD (12,26,9)

2157.59, 2139.19, 24.14
Indicator MACD is in positive zone

Indicator ADX (14)

15.72, 19.52, 14.21
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
23 Fri Jan 2026 2137.15 2129.65 to 2171.00 -1.29% 1.08 times
22 Thu Jan 2026 2165.05 2141.25 to 2189.00 1.2% 0.37 times
21 Wed Jan 2026 2139.40 2134.20 to 2210.40 -1.23% 0.8 times
20 Tue Jan 2026 2166.10 2152.10 to 2179.00 -0.56% 0.95 times
19 Mon Jan 2026 2178.20 2145.45 to 2188.00 0.09% 0.64 times
16 Fri Jan 2026 2176.25 2173.25 to 2216.95 -0.85% 0.86 times
14 Wed Jan 2026 2195.00 2158.00 to 2215.20 0.84% 0.9 times
13 Tue Jan 2026 2176.80 2156.60 to 2206.40 -0.59% 3.26 times
12 Mon Jan 2026 2189.75 2143.15 to 2198.95 0.38% 0.68 times
09 Fri Jan 2026 2181.45 2156.15 to 2194.30 -0.41% 0.7 times
08 Thu Jan 2026 2190.50 2186.00 to 2228.35 -1.04% 0.86 times
07 Wed Jan 2026 2213.55 2144.55 to 2225.25 2.86% 4.27 times

Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500257 announcements Lupin Ltd. announcements and dividends declared BSE

 

Back to top